Cyclooxygenase-2 (COX-2) as a Target of Anticancer Agents: A Review of Novel Synthesized Scaffolds Having Anticancer and COX-2 Inhibitory Potentialities

Cyclooxygenase-2 (COX-2) as a Target of Anticancer Agents: A Review of Novel Synthesized Scaffolds Having Anticancer and COX-2 Inhibitory Potentialities

Cancer is a serious threat to human beings and is the second-largest cause of death all over the globe. Chemotherapy is one of the most common treatments for cancer; however, drug resistance and severe adverse effects are major problems associated with anticancer therapy. New compounds with multi-ta...

Full description

Bibliographic Details
Main Authors: Noor ul Amin Mohsin, Sana Aslam, Matloob Ahmad, Muhammad Irfan, Sami A. Al-Hussain, Magdi E. A. Zaki
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:Pharmaceuticals
Subjects:
drug design
hybrid molecules
cancer cell lines
molecular docking
COX-2
Online Access:https://www.mdpi.com/1424-8247/15/12/1471

Internet

https://www.mdpi.com/1424-8247/15/12/1471

Similar Items